BBP vs. QQQ
BBP (Virtus LifeSci Biotech Products ETF) and QQQ (Invesco QQQ ETF) are both exchange-traded funds - BBP is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Products Index, while QQQ is a Nasdaq-100 fund tracking the NASDAQ-100 Index. Both are passively managed. Over the past 10 years, BBP returned 13.69%/yr vs 22.07%/yr for QQQ. A 0.53 correlation means they provide meaningful diversification when combined. BBP charges 0.79%/yr vs 0.18%/yr for QQQ.
Performance
BBP vs. QQQ - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with BBP having a 16.04% return and QQQ slightly higher at 16.45%. Over the past 10 years, BBP has underperformed QQQ with an annualized return of 13.69%, while QQQ has yielded a comparatively higher 22.07% annualized return.
BBP
- 1D
- 1.20%
- 1M
- 7.69%
- YTD
- 16.04%
- 6M
- 14.38%
- 1Y
- 59.95%
- 3Y*
- 20.40%
- 5Y*
- 11.34%
- 10Y*
- 13.69%
QQQ
- 1D
- -3.29%
- 1M
- -0.43%
- YTD
- 16.45%
- 6M
- 14.99%
- 1Y
- 34.88%
- 3Y*
- 26.05%
- 5Y*
- 16.01%
- 10Y*
- 22.07%
BBP vs. QQQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 16.04% | 33.15% | 3.32% | 17.88% | 0.85% | -8.17% | 22.24% | 24.73% | -13.95% | 24.07% |
QQQ Invesco QQQ ETF | 16.45% | 20.77% | 25.58% | 54.86% | -32.58% | 27.42% | 48.62% | 38.96% | -0.13% | 32.66% |
Correlation
The correlation between BBP and QQQ is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.39 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.44 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.49 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.52 |
Correlation (All Time) Calculated using the full available price history since Dec 17, 2014 | 0.53 |
The correlation between BBP and QQQ shifts across timeframes, from 0.39 (1 year) to 0.53 (all time), reflecting how their relationship changes across market environments.
BBP vs. QQQ - Sectors Allocation Comparison
Sectors
BBP
QQQ
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
BBP
QQQ
Basic Materials
BBP
-
QQQ
Communication Services
BBP
-
QQQ
Consumer Cyclical
BBP
-
QQQ
Consumer Defensive
BBP
-
QQQ
Energy
BBP
-
QQQ
Financial Services
BBP
-
QQQ
Industrials
BBP
-
QQQ
Real Estate
BBP
-
QQQ
Technology
BBP
-
QQQ
Utilities
BBP
-
QQQ
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBP vs. QQQ — Risk / Return Rank
BBP
QQQ
BBP vs. QQQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBP | QQQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.56 | ||
| Sortino ratioReturn per unit of downside risk | +0.85 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.35 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 6.49 | 2.93 | +3.56 |
| Martin ratioReturn relative to average drawdown | 20.18 | 10.86 | +9.32 |
Loading charts...
Drawdowns
BBP vs. QQQ - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum QQQ drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for BBP and QQQ.
Loading charts...
Drawdown Indicators
| BBP | QQQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -82.97% | +38.65% |
Max Drawdown (1Y)Largest decline over 1 year | -9.28% | -11.96% | +2.68% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | -22.77% | -3.32% |
Max Drawdown (5Y)Largest decline over 5 years | -37.89% | -35.12% | -2.77% |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | -35.12% | -9.20% |
Current DrawdownCurrent decline from peak | 0.00% | -4.25% | +4.25% |
Average DrawdownAverage peak-to-trough decline | -11.98% | -32.73% | +20.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.98% | 3.22% | -0.24% |
Volatility
BBP vs. QQQ - Volatility Comparison
The current volatility for Virtus LifeSci Biotech Products ETF (BBP) is 6.46%, while Invesco QQQ ETF (QQQ) has a volatility of 9.17%. This indicates that BBP experiences smaller price fluctuations and is considered to be less risky than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBP | QQQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.46% | 9.17% | -2.71% |
Volatility (6M)Calculated over the trailing 6-month period | 18.88% | 14.57% | +4.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.96% | 17.96% | +6.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.37% | 22.69% | +3.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.39% | 22.42% | +4.97% |
BBP vs. QQQ - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is higher than QQQ's 0.18% expense ratio.
Dividends
BBP vs. QQQ - Dividend Comparison
BBP has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.43%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
QQQ Invesco QQQ ETF | 0.43% | 0.45% | 0.56% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% |
Frequently Asked Questions
BBP and QQQ have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QQQ has higher volatility (9.17%) compared to BBP (6.46%). In terms of maximum drawdown, BBP dropped -44.32% vs QQQ's -82.97%.
On 10-year performance, QQQ leads with 22.07% vs 13.69% for BBP. On fees, QQQ is cheaper at 0.18% per year. On volatility, BBP has been the lower-risk option at 6.46%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, QQQ has performed better with a 22.07% return vs 13.69%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
QQQ is cheaper with a 0.18% expense ratio, compared with 0.79% for BBP.
QQQ has the higher dividend yield at 0.43%, compared with 0.00% for BBP.
BBP is categorized as Health & Biotech Equities, while QQQ is Nasdaq-100. BBP tracks LifeSci Biotechnology Products Index, while QQQ tracks NASDAQ-100 Index. They also come from different issuers: Virtus Investment Partners and Invesco. Their fees differ too: 0.79% for BBP and 0.18% for QQQ.
BBP currently has the higher Sharpe Ratio (2.52 vs 1.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBP and QQQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer